Clinical Trial Update: PAZOPANIB Efficacy and Tolerance in Desmoids Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pazopanib for progressive desmoid-type fibromatosis reports efficacy and tolerability results. The study is completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid-type Fibromatosis

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Institut Bergonié | Conditions: Progressive Desmoids Tumors | Phase 2 | Status: COMPLETED | Results posted: 2021-03-05